Kinetics of the Neutralizing and Spike SARS-CoV-2 Antibodies following the Sinovac Inactivated Virus Vaccine Compared to the Pfizer mRNA Vaccine in Singapore.

Lau, Chin Shern; Oh, May Lin Helen; Phua, Soon Kieng; Liang, Ya Li; Li, Yanfeng; Huo, Jianxin; Huang, Yuhan; Zhang, Biyan; Xu, Shengli; Aw, Tar Choon

Lau, Chin Shern; Oh, May Lin Helen; Phua, Soon Kieng; Liang, Ya Li; Li, Yanfeng; Huo, Jianxin; Huang, Yuhan; Zhang, Biyan; Xu, Shengli; Aw, Tar Choon.

Afiliação

Lau CS; Department of Laboratory Medicine, Changi General Hospital, Singapore 529889, Singapore.
Oh MLH; Department of Infectious Diseases, Changi General Hospital, Singapore 529889, Singapore.
Phua SK; Department of Laboratory Medicine, Changi General Hospital, Singapore 529889, Singapore.
Liang YL; Department of Laboratory Medicine, Changi General Hospital, Singapore 529889, Singapore.
Li Y; GenScript Biotech (Singapore) Pte Ltd., Singapore 349248, Singapore.
Huo J; Singapore Immunology Network, Agency for Science, Technology and Research, Singapore 138648, Singapore.
Huang Y; Singapore Immunology Network, Agency for Science, Technology and Research, Singapore 138648, Singapore.
Zhang B; Singapore Immunology Network, Agency for Science, Technology and Research, Singapore 138648, Singapore.
Xu S; Singapore Immunology Network, Agency for Science, Technology and Research, Singapore 138648, Singapore.
Aw TC; Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117599, Singapore.

Antibodies (Basel) ; 11(2)2022 May 27.

Article em En | MEDLINE | ID: mdl-35735357

Palavras-chave

SARS-CoV-2; antibodies; inactivated virus vaccine; mRNA vaccine

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Antibodies (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Singapura

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google